ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
World Health Organization, 2001. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overview and Estimates. Geneva: World Health Organization.
-
2.
Cotch MF, Pastorek JG 2nd, Nugent RP, Hillier SL, Gibbs RS, Martin DH, Eschenbach DA, Edelman R, Carey JC, Regan JA, Krohn MA, Klebanoff MA, Rao AV, Rhoads GG, 1997. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex Transm Dis 24: 353– 360.
-
3.
Minkoff H, Grunebaum AN, Schwarz RH, Feldman J, Cummings M, Crombleholme W, Clark L, Pringle G, McCormack WM, 1984. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol 150: 965– 972.
-
4.
McClelland RS, Sangare L, Hassan WM, Lavreys L, Mandaliya K, Kiarie J, Ndinya-Achola J, Jaoko W, Baeten JM, 2007. Infection with Trichomonas vaginalis increases the risk of HIV acquisition. J Infect Dis 195: 698– 702.
-
5.
Sorvillo F, Smith L, Kerndt P, Ash L, 2001. Trichomonas vaginalis, HIV, and African-Americans. Emerg Infect Dis 7: 927– 932.
-
6.
Zhang ZF, Begg CB, 1994. Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies. Int J Epidemiol 23: 682– 690.
-
7.
Stark JR, Judson G, Alderete JF, Mundodi V, Kucknoor AS, Giovannucci EL, Platz EA, Sutcliffe S, Fall K, Kurth T, Ma J, Stampfer MJ, Mucci LA, 2009. Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: physicians' Health Study. J Natl Cancer Inst 101: 1406– 1411.
-
8.
Schmid G, Narcisi E, Mosure D, Secor WE, Higgins J, Moreno H, 2001. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic. J Reprod Med 46: 545– 549.
-
9.
Narcisi EM, Secor WE, 1996. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis. Antimicrob Agents Chemother 40: 1121– 1125.
-
10.
Upcroft P, Upcroft JA, 2001. Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin Microbiol Rev 14: 150– 164.
-
11.
Dunne RL, Dunn LA, Upcroft P, O'Donoghue PJ, Upcroft JA, 2003. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis. Cell Res 13: 239– 249.
-
12.
Carlton JM, Hirt RP, Silva JC, Delcher AL, Schatz M, Zhao Q, Wortman JR, Bidwell SL, Alsmark UC, Besteiro S, Sicheritz-Ponten T, Noel CJ, Dacks JB, Foster PG, Simillion C, Van de Peer Y, Miranda-Saavedra D, Barton GJ, Westrop GD, Müller S, Dessi D, Fiori PL, Ren Q, Paulsen I, Zhang H, Bastida-Corcuera FD, Simoes-Barbosa A, Brown MT, Hayes RD, Mukherjee M, Okumura CY, Schneider R, Smith AJ, Vanacova S, Villalvazo M, Haas BJ, Pertea M, Feldblyum TV, Utterback TR, Shu CL, Osoegawa K, de Jong PJ, Hrdy I, Horvathova L, Zubacova Z, Dolezal P, Malik SB, Logsdon JM Jr, Henze K, Gupta A, Wang CC, Dunne RL, Upcroft JA, Upcroft P, White O, Salzberg SL, Tang P, Chiu CH, Lee YS, Embley TM, Coombs GH, Mottram JC, Tachezy J, Fraser-Liggett CM, Johnson PJ, 2007. Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis. Science 315: 207– 212.
-
13.
Lossick JG, Muller M, Gorrell TE, 1986. In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis. J Infect Dis 153: 948– 955.
-
14.
Meade JC, de Mestral J, Stiles JK, Secor WE, Finley RW, Cleary JD, Lushbaugh WB, 2009. Genetic diversity of Trichomonas vaginalis clinical isolates determined by EcoRI restriction fragment length polymorphism of heat-shock protein 70 genes. Am J Trop Med Hyg 80: 245– 251.
-
15.
Hampl V, Pavlíček A, Flegr J, 2001. Construction and bootstrap analysis of DNA fingerprinting-based phylogenetic trees with the freeware program FreeTree: application to trichomonad parasites. Int J Syst Evol Microbiol 51: 731– 735.
-
16.
Saitou N, Mei M, 1987. The neighbor-joining method: a new method for reconstruction of phylogenetic trees. Mol Biol Evol 4: 406– 425.
-
17.
Nei M, Li W-H, 1979. Mathematical model for studying genetic variation in terms of restriction endonucleases. Proc Natl Acad Sci U S A 76: 5269– 5273.
-
18.
Campos Aldrete ME, Salgado-Zamora H, Luna J, Meléndez E, Meráz-Ríos MA, 2005. A high-throughput colorimetric and fluorometric microassay for the evaluation of nitroimidazole derivatives anti-Trichomonas activity. Toxicol In Vitro 19: 1045– 1050.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 242 | 225 | 43 |
| Full Text Views | 288 | 20 | 2 |
| PDF Downloads | 90 | 17 | 2 |
Genetic Relatedness of Trichomonas vaginalis Reference and Clinical Isolates
Denise C. Cornelius
Denise C. Cornelius
Department of Microbiology and Department of Medicine, Division of Infectious Diseases, University of Mississippi Medical Center, Jackson, Mississippi
Search for other papers by Denise C. Cornelius in
Current site
Google Scholar
PubMed
Search for other papers by Denise C. Cornelius in
Current site
Google Scholar
PubMed
Leandro Mena
Leandro Mena
Department of Microbiology and Department of Medicine, Division of Infectious Diseases, University of Mississippi Medical Center, Jackson, Mississippi
Search for other papers by Leandro Mena in
Current site
Google Scholar
PubMed
Search for other papers by Leandro Mena in
Current site
Google Scholar
PubMed
William B. Lushbaugh
William B. Lushbaugh
Department of Microbiology and Department of Medicine, Division of Infectious Diseases, University of Mississippi Medical Center, Jackson, Mississippi
Search for other papers by William B. Lushbaugh in
Current site
Google Scholar
PubMed
Search for other papers by William B. Lushbaugh in
Current site
Google Scholar
PubMed
John C. Meade
John C. Meade
Department of Microbiology and Department of Medicine, Division of Infectious Diseases, University of Mississippi Medical Center, Jackson, Mississippi
Search for other papers by John C. Meade in
Current site
Google Scholar
PubMed
Search for other papers by John C. Meade in
Current site
Google Scholar
PubMed
We have determined the metronidazole susceptibility status of 20 Trichomonas vaginalis isolates from American Type Culture Collection (ATCC) and assessed the level of genetic relatedness in these isolates using 32 additional T. vaginalis clinical isolates for comparison. These ATCC isolates are commonly used as reference strains in T. vaginalis research and this information provides a rational basis for selection of reference strains for use in comparative studies of T. vaginalis phenotypic and clinical characteristics.
Author Notes
Financial support: This work was partially funded by the Mississippi Institute for Improvement of Geographic Minority Health.
Authors' addresses: Denise C. Cornelius, William B. Lushbaugh, and John C. Meade, Department of Microbiology, University of Mississippi Medical Center, Jackson, MS, E-mails: dcornelius@umc.edu, wlushbaugh@umc.edu, and jmeade@umc.edu. Leandro Mena, Department of Medicine, Division of Infectious Disease, University of Mississippi Medical Center, Jackson, MS, E-mail: lmena@umc.edu.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
World Health Organization, 2001. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overview and Estimates. Geneva: World Health Organization.
-
2.
Cotch MF, Pastorek JG 2nd, Nugent RP, Hillier SL, Gibbs RS, Martin DH, Eschenbach DA, Edelman R, Carey JC, Regan JA, Krohn MA, Klebanoff MA, Rao AV, Rhoads GG, 1997. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex Transm Dis 24: 353– 360.
-
3.
Minkoff H, Grunebaum AN, Schwarz RH, Feldman J, Cummings M, Crombleholme W, Clark L, Pringle G, McCormack WM, 1984. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol 150: 965– 972.
-
4.
McClelland RS, Sangare L, Hassan WM, Lavreys L, Mandaliya K, Kiarie J, Ndinya-Achola J, Jaoko W, Baeten JM, 2007. Infection with Trichomonas vaginalis increases the risk of HIV acquisition. J Infect Dis 195: 698– 702.
-
5.
Sorvillo F, Smith L, Kerndt P, Ash L, 2001. Trichomonas vaginalis, HIV, and African-Americans. Emerg Infect Dis 7: 927– 932.
-
6.
Zhang ZF, Begg CB, 1994. Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies. Int J Epidemiol 23: 682– 690.
-
7.
Stark JR, Judson G, Alderete JF, Mundodi V, Kucknoor AS, Giovannucci EL, Platz EA, Sutcliffe S, Fall K, Kurth T, Ma J, Stampfer MJ, Mucci LA, 2009. Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: physicians' Health Study. J Natl Cancer Inst 101: 1406– 1411.
-
8.
Schmid G, Narcisi E, Mosure D, Secor WE, Higgins J, Moreno H, 2001. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic. J Reprod Med 46: 545– 549.
-
9.
Narcisi EM, Secor WE, 1996. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis. Antimicrob Agents Chemother 40: 1121– 1125.
-
10.
Upcroft P, Upcroft JA, 2001. Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin Microbiol Rev 14: 150– 164.
-
11.
Dunne RL, Dunn LA, Upcroft P, O'Donoghue PJ, Upcroft JA, 2003. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis. Cell Res 13: 239– 249.
-
12.
Carlton JM, Hirt RP, Silva JC, Delcher AL, Schatz M, Zhao Q, Wortman JR, Bidwell SL, Alsmark UC, Besteiro S, Sicheritz-Ponten T, Noel CJ, Dacks JB, Foster PG, Simillion C, Van de Peer Y, Miranda-Saavedra D, Barton GJ, Westrop GD, Müller S, Dessi D, Fiori PL, Ren Q, Paulsen I, Zhang H, Bastida-Corcuera FD, Simoes-Barbosa A, Brown MT, Hayes RD, Mukherjee M, Okumura CY, Schneider R, Smith AJ, Vanacova S, Villalvazo M, Haas BJ, Pertea M, Feldblyum TV, Utterback TR, Shu CL, Osoegawa K, de Jong PJ, Hrdy I, Horvathova L, Zubacova Z, Dolezal P, Malik SB, Logsdon JM Jr, Henze K, Gupta A, Wang CC, Dunne RL, Upcroft JA, Upcroft P, White O, Salzberg SL, Tang P, Chiu CH, Lee YS, Embley TM, Coombs GH, Mottram JC, Tachezy J, Fraser-Liggett CM, Johnson PJ, 2007. Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis. Science 315: 207– 212.
-
13.
Lossick JG, Muller M, Gorrell TE, 1986. In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis. J Infect Dis 153: 948– 955.
-
14.
Meade JC, de Mestral J, Stiles JK, Secor WE, Finley RW, Cleary JD, Lushbaugh WB, 2009. Genetic diversity of Trichomonas vaginalis clinical isolates determined by EcoRI restriction fragment length polymorphism of heat-shock protein 70 genes. Am J Trop Med Hyg 80: 245– 251.
-
15.
Hampl V, Pavlíček A, Flegr J, 2001. Construction and bootstrap analysis of DNA fingerprinting-based phylogenetic trees with the freeware program FreeTree: application to trichomonad parasites. Int J Syst Evol Microbiol 51: 731– 735.
-
16.
Saitou N, Mei M, 1987. The neighbor-joining method: a new method for reconstruction of phylogenetic trees. Mol Biol Evol 4: 406– 425.
-
17.
Nei M, Li W-H, 1979. Mathematical model for studying genetic variation in terms of restriction endonucleases. Proc Natl Acad Sci U S A 76: 5269– 5273.
-
18.
Campos Aldrete ME, Salgado-Zamora H, Luna J, Meléndez E, Meráz-Ríos MA, 2005. A high-throughput colorimetric and fluorometric microassay for the evaluation of nitroimidazole derivatives anti-Trichomonas activity. Toxicol In Vitro 19: 1045– 1050.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 242 | 225 | 43 |
| Full Text Views | 288 | 20 | 2 |
| PDF Downloads | 90 | 17 | 2 |